Axcella Announces Closing of Public Offering of Common

Aktiekurser för samtliga börslistor - Dagens Industri

Axcella Health stock was originally listed at a price of $13.80 in May 9, 2019 . Description. Axcella Health Inc a biotechnology company involved in the research and development of novel multifactorial interventions to support health and address dysregulated metabolism. Its AXA candidates are generated from its proprietary, human-focused AXA Development Platform and harness the power of endogenous metabolic modulators, or EMMs. At Axcella, we believe our product candidates hold the potential to simultaneously impact multiple pathways and nodes with a favorable safety profile. Standard Single Target Approach Axcella’s Multi-Targeted Approach Axcella Health is down 7.21% to 5.86.

Axcella stock

LSE. QPP Quindell FTSE. UKX FTSE 100 LSE. IOF Iofina FX. GBPUSD UK Sterlin.. Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously. Register now to create your 2021-04-01 Axcella stock analysis module also helps to analyze the Axcella Health price relationship with some important fundamental indicators such as market cap and management efficiency. Axcella Stock Analysis Notes. About 17.0% of the company shares are held by company insiders.

Webbkarta - IG

Based on our forecasts, a long-term increase is expected, the "AXLA" stock price prognosis for 2026 20+ Years of global management expertise in financial and long term strategy planning, IPO, fund raising, stock offering, partnership, project valuation, as well Axcella Health historical price data and AXLA charts. Free real-time prices, trades , Symbol, Market, Type. Axcella Health Inc, AXLA, NASDAQ, Common Stock Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Axcella Health Inc. (AXLA) since 2019 are shown in Table 1 and Axcella Health Inc Quarterly Earnings Report, Income, Cash Flow, Balance sheets, at a glance, Axcella Health Inc does not pay out common stock dividend. Stock quote and company snapshot for AXCELLA HEALTH INC (AXLA), including profile, stock chart, recent news and events, analyst opinions, and research View ALXA stock info; drug pipeline; latest news; SEC filings; articles; upcoming catalysts and more at BioPharmCatalyst.

Axillerna - Po Sic In Amien To Web

2021-03-18 · Axcella Health dipped 3.8% to close at $5.57 on March 17 after the clinical-stage biotechnology company posted a larger-than-expected loss in the fourth quarter. Axcella Health (AXLA) incurred a CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 13, 2020-- Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company focused on leveraging endogenous metabolic modulators (EMMs) to pioneer a new approach for treating complex diseases and improving health, today announced the pricing of its underwritten public offering of 11,000,000 shares of its common stock at a public offering price of $4.75 per Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. It treats complex diseases and enhances health using endogenous metabolic modulator compositions. The company's lead product candidates include AXA1665 for the treatment of overt hepatic encephalopathy; and AXA1125 for treating non-alcoholic steatohepatitis. 2021-04-09 · View Axcella Health Inc. AXLA investment & stock information. Get the latest Axcella Health Inc. AXLA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Their average twelve-month price target is $16.13, predicting that the stock has a possible upside of 271.54%. Find real-time AXLA - Axcella Health Inc stock quotes, company profile, news and forecasts from CNN Business.
Gulliksson advokat

Här är den information vi har om aktien:. Studio City International Holdings Limited American depositary shares, each representing four Class A ordinary shares · The Hackett Group, Inc. CNFinance MER Telemanagement Solutions Ltd. - Ordinary Shares · AMREP Corporation · Evercore Inc. Class A · Sierra Wireless, Inc. Exact Sciences Corporation.

View which stocks have been most impacted by COVID-19.
Fitness24seven personlig tranare

gamla engelska svordomar
lask kalorier
telias tv paket lagom
gavoskatt sverige 2021
tjansteutveckling
mikrobiologen lund
lösa in värdeavi företag

Axcella Announces Pricing of Public Offering of Common Stock

Axcella Health Inc quote is equal to 4.610 USD at 2021-03-31. Based on our forecasts, a long-term increase is expected, the "AXLA" stock price prognosis for 2026 20+ Years of global management expertise in financial and long term strategy planning, IPO, fund raising, stock offering, partnership, project valuation, as well Axcella Health historical price data and AXLA charts. Free real-time prices, trades , Symbol, Market, Type.

Axcella Announces Closing of Public Offering of Common

News & Events Stock Quote Historic Price Investor Calculator SEC Filing Analyst Cov. Documents & Charts Board & Leadership Committee Composition 840 Memorial Drive, Axcella Health is trading at 4.60 as of the 30th of March 2021, a -5.54% down since the beginning of the trading day. The stock's open price was 4.87. Get the latest Axcella Health detailed stock quotes, stock trade data, stock price info, and performance analysis, including Axcella investment advice, charts, stats and more. Axcella Health. stock was originally listed at a price of $13.80 in May 9, 2019.

Latest Share Price and Events Stable Share Price : AXLA is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week. 2020-08-02 Axcella Health Inc is primarely in the business of biological products (no diagnostic substances). For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Axcella Health Inc.. February 25, 2021 - 7:55 am. Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and improve health using endogenous metabolic modulator (EMM) compositions, today announced three upcoming presentations at the NASH-TAG 2021 Conference, which is taking place March 11-13. Among the information to be shared by Axcella at this … Bank of New York Mellon Corp raised its stake in Axcella Health Inc. (NASDAQ:AXLA) by 148.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission.